• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    KalVista Presents Sebetralstat Data at Allergy Congress 2024

    BUSINESSWIRE

    KalVista Presents Sebetralstat Data At HAEi Global Forum

    BUSINESSWIRE

    KalVista To Present Nine Abstracts At HAEi GAF

    BUSINESSWIRE

    KalVista Pharmaceuticals Presents Sebetralstat Data at Bradykinin Symposium 2024

    BUSINESSWIRE

    KalVista Pharmaceuticals Reports Fiscal Q1 Results and Operational Update

    BUSINESSWIRE

    KalVista Announces FDA Acceptance of Sebetralstat for Hereditary Angioedema

    BUSINESSWIRE

    KalVista’s Sebetralstat Application Validated By European Medicines Agency

    BUSINESSWIRE

    KalVista Submits NDA To FDA For Sebetralstat as Oral Treatment Angioedema

    BUSINESSWIRE

    KalVista Oral Sebetralstat Phase 3 Data In NEJM For Hereditary Angioedema

    BUSINESSWIRE

    KalVista Awarded UK PIM Designation for Sebetralstat

    BUSINESSWIRE

    KalVista Pharmaceuticals Awarded UK Innovation Passport for Sebetralstat

    BUSINESSWIRE

    KalVista Pharmaceuticals to Present Phase 3 Sebetralstat Data

    BUSINESSWIRE

    KalVista Announces Phase 1 Data for Tablet Formulation of Sebetralstat

    BUSINESSWIRE

    KalVista Announces Publications in Journal of Medicinal Chemistry & Xenobiotica

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.